ZZ

Zeev Zehavi

Vice President, Venture Investments, Johnson & Johnson Innovation — JJDC

Petah Tikva, Center District

Overview 

Zeev Zehavi is the Vice President of Venture Investments at Johnson & Johnson Innovation — JJDC, with a background in leadership roles at Clal Industries and Teva Pharmaceuticals. He holds an MBA from Tel Aviv University and a BS from The Hebrew University of Jerusalem.

Work Experience 

J&

Johnson & Johnson

  • Vice President, Venture Investments, Johnson & Johnson Innovation — JJDC

    1999 - 2022

    Focuses on Venture investments in Israel in all three J&J sectors and on Medical Devices in Europe in support of J&J strategic objectives. Works closely with London Innovation Center colleagues, Therapeutic Areas, Business Development and R&D Functional Areas.

Johnson & Johnson is a healthcare provider, expertise in innovative medicine and MedTech for every patient & for everyone.

jnj.com
CI

Clal Industries

  • President, Clal Pharmaceuticals

    1994 - 1998

    Focus on Private equity investments in companies in the field of Generic products, Drug delivery and Chiral chemistry: Pharmaceutical resource inc., Biodar Ltd., FineTech Pharmaceutical.

TP

Teva Pharmaceuticals

  • President, Plantex USA

    1988 - 1993

    Managing API sales of bulk chemicals and Oncology hospital products in the US and Canada

  • Area Export Sales Manager for Central America

    1983 - 1988

    Responsible for sales for all Teva Product portfolio in the region including Finished dose generics, API, Consumer products and Sutures.

ID

Israel Defense Forces

  • Military Service, Intelligence Forces

    1972 - 1978

    Rank: Major, honorable discharge

Education 

Articles About Zeev

Relevant Websites